Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

NIH signs on IDT Biologika to manufacture clinical trial supply

The NIH has contracted IDT Biologika to manufacture five E. coli master cell banks for BLA, IND, and Phase I/II trial supply.

Wacker Chemie turns to biopharma during period of uncertainty

Wacker Biotech looks to corner the microbial expression system niche, as Wacker Chemie’s traditional areas of focus face difficult market conditions.

Boehringer looks to oncology vaccines with €325m acquisition

Boehringer takes on AMAL to gain access to its cancer vaccine technology, with a lead candidate due to enter first-in-human studies this month.

‘Dead cells don’t cure cancer’: BioLife acquires cold-chain solutions

BioLife exercises its option to acquire the remaining shares of the cold chain management company, SAVSU.

US failure to adopt biosimilars costs $7.2bn every year

With US spending on biologics reaching $125.5bn in 2018, a new report looks at the level of savings that could potentially be made and contrasts the US with the European market.

Global Industry News

Hot Topics

Spotlight

Paragon’s Maryland facility adds Passage Bio’s manufacturing suite

Erytech-SQZ collaboration to ‘realize immune-modulating potential’

Grifols expands in Africa with manufacturing facility

BioNTech aims to advance pipeline to the clinic with $325m investment

Emergex develops synthetic hand-foot-and-mouth vaccine

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics